G. Steven Burrill

Chief Executive Officer, Burrill & Company

Mr. Burrill is the Chief Executive Officer of Burrill & Company LLC, a merchant bank that provides venture capital, media and strategic partnering services and focuses on biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, healthcare delivery, nutraceuticals and wellness, agricultural biotechnology, industrial biotechnology and biofuels. Prior to founding Burrill & Company, he spent 27 years with Ernst & Young LLP. He is currently a member of the board of directors of DepoMed, Inc. Mr. Burrill has been a member of Targacept’s board of directors since August 2006 and also served as a member of the Board from August 2000 to August 2005. He serves on the Audit Committee.